Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
41.65
+1.60 (4.00%)
May 18, 2026, 3:57 PM EDT - Market open
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $204.58M in the quarter ending March 31, 2026, with 1.62% growth. This brings the company's revenue in the last twelve months to $915.25M, up 8.94% year-over-year. In the year 2025, Inspire Medical Systems had annual revenue of $911.98M with 13.60% growth.
Revenue (ttm)
$915.25M
Revenue Growth
+8.94%
P/S Ratio
1.30
Revenue / Employee
$686,607
Employees
1,333
Market Cap
1.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 911.98M | 109.18M | 13.60% |
| Dec 31, 2024 | 802.80M | 178.01M | 28.49% |
| Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
| Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
| Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
| Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
| Dec 31, 2019 | 82.05M | 31.46M | 62.18% |
| Dec 31, 2018 | 50.59M | 22.03M | 77.10% |
| Dec 31, 2017 | 28.57M | 12.14M | 73.90% |
| Dec 31, 2016 | 16.43M | 8.42M | 105.03% |
| Dec 31, 2015 | 8.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.29B |
| Enovis | 2.28B |
| Integra LifeSciences Holdings | 1.64B |
| CONMED | 1.37B |
| Alphatec Holdings | 787.08M |
| Avanos Medical | 715.90M |
| Bioventus | 576.30M |
| Artivion | 458.69M |
INSP News
- 5 days ago - Inspire Medical Systems Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 13 days ago - Inspire Medical price target lowered to $50 from $64 at Truist - TheFly
- 13 days ago - Inspire Medical price target lowered to $54 from $67 at JPMorgan - TheFly
- 13 days ago - Inspire Medical price target lowered to $55 from $62 at Evercore ISI - TheFly
- 13 days ago - Inspire Medical price target lowered to $45 from $56 at RBC Capital - TheFly
- 13 days ago - Inspire Medical price target lowered to $55 from $70 at Mizuho - TheFly
- 13 days ago - Inspire Medical price target lowered to $65 from $70 at Stifel - TheFly
- 13 days ago - Piper downgrades Inspire Medical to Neutral on guidance cut - TheFly